OptimizeRx (NASDAQ:OPRX) will be announcing its earnings results after the market closes on Wednesday, August 7th. Analysts expect the company to announce earnings of $0.03 per share for the quarter.
Shares of NASDAQ:OPRX opened at $14.97 on Wednesday. The business has a fifty day moving average of $15.28. The company has a market cap of $188.56 million, a price-to-earnings ratio of 299.40, a price-to-earnings-growth ratio of 1.76 and a beta of 0.51. OptimizeRx has a one year low of $8.92 and a one year high of $18.39. The company has a quick ratio of 4.02, a current ratio of 4.02 and a debt-to-equity ratio of 0.03.
Separately, Zacks Investment Research lowered shares of Hess Midstream Partners from a “hold” rating to a “sell” rating in a report on Tuesday, May 14th. Four investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. OptimizeRx currently has a consensus rating of “Buy” and an average price target of $19.00.
In other news, major shareholder Awm Investment Company, Inc. sold 82,126 shares of the stock in a transaction on Monday, May 13th. The shares were sold at an average price of $13.64, for a total value of $1,120,198.64. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.
OptimizeRx Corporation provides digital health messaging services for pharmaceutical companies to communicate with healthcare providers. The company's cloud-based solutions support patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and critical clinical information; and network consists of electronic health records platforms, which provide the ambulatory patient market with access to their workflow at the point-of-care.
Featured Article: What is Cost of Capital?
Receive News & Ratings for OptimizeRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx and related companies with MarketBeat.com's FREE daily email newsletter.